Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
autoimmune disease
Biotech
Roivant's inflammatory med is back on track with ph. 2 NIU data
Roivant CEO Matt Gline said the company is constantly considering new indications to add to brepocitinib's development plan.
Max Bayer
Apr 2, 2024 10:37am
Ginkgo loads up Modulus CAR assets, latest in a string of deals
Apr 2, 2024 7:01am
A new biotech blooms with $100M to take on small molecules
Feb 29, 2024 9:30am
Ono taps Shattuck for $227M bifunctional fusion protein deal
Feb 13, 2024 8:29am
Kyverna CEO: 'We're in the next phase of medicine'
Feb 9, 2024 1:57pm
Kyverna raises IPO expectations to almost $300M
Feb 6, 2024 9:46am